公开(公告)号：US09474703B2

公开(公告)日：2016-10-25

申请号：US14561447

申请日：2014-12-05

Applicant: Ecolab USA Inc.

Inventor： Daniel E. Pedersen ,  Angela R. Eder ,  Charles Allen Hodge

IPC: A01N25/30 ,  A01N47/44 ,  A01N33/12 ,  A61K8/43 ,  C11D3/30 ,  C11D1/88 ,  C11D1/62 ,  C11D1/94 ,  C11D1/835 ,  C11D1/75 ,  C11D3/22 ,  C11D1/66 ,  A01N25/16 ,  A61K8/40 ,  A61K8/41 ,  A61K8/60 ,  A61Q17/00 ,  A61Q19/10

CPC classification number: A61K8/43 ,  A01N25/16 ,  A01N25/30 ,  A01N33/12 ,  A01N47/44 ,  A61K8/40 ,  A61K8/416 ,  A61K8/60 ,  A61K8/604 ,  A61K2800/30 ,  A61Q17/005 ,  A61Q19/10 ,  C11D1/62 ,  C11D1/662 ,  C11D1/75 ,  C11D1/835 ,  C11D1/88 ,  C11D1/94 ,  C11D3/22 ,  C11D3/30 ,  A01N2300/00

Abstract: The antimicrobial composition of the present invention comprises a cationic active ingredient, a quaternized sugar-derived surfactant, and an optional foam boosting surfactant. These formulations have a high cidal activity in a short amount of time and provide stable copious foam. The formulations of the present invention also exhibit enhanced tissue (e.g. skin) compatibility as defined by an in vitro whole toxicology assessment method.

公开(公告)号：US20150290100A1

公开(公告)日：2015-10-15

申请号：US14748848

申请日：2015-06-24

Applicant: Ecolab USA Inc.

Inventor： Angela R. Eder ,  Daniel E. Pedersen ,  Charles Allen Hodge

IPC: A61K8/43 ,  A61K8/40 ,  A61K8/41 ,  A61K8/60 ,  A61Q19/10 ,  A61Q17/00

CPC classification number: A61K8/43 ,  A01N25/16 ,  A01N25/30 ,  A01N33/12 ,  A01N47/44 ,  A61K8/40 ,  A61K8/416 ,  A61K8/60 ,  A61K8/604 ,  A61K2800/30 ,  A61Q17/005 ,  A61Q19/10 ,  C11D1/62 ,  C11D1/662 ,  C11D1/75 ,  C11D1/835 ,  C11D1/88 ,  C11D1/94 ,  C11D3/22 ,  C11D3/30 ,  A01N2300/00

Abstract: The antimicrobial composition of the present invention comprises a cationic active ingredient, a quaternized sugar-derived surfactant, and an optional foam boosting surfactant. The present antimicrobial compositions are free of the antimicrobial agent triclosan (i.e., 2,4,4′-trichloro-2′hydroxy-diphenylether), have a high cidal activity in a short amount of time, provide stable copious foam and exhibit enhanced tissue (e.g. skin) compatibility as defined by an in vitro whole toxicology assessment method.

Abstract translation: 本发明的抗微生物组合物包含阳离子活性成分，季铵化的糖衍生的表面活性剂和任选的泡沫促进表面活性剂。 本抗微生物组合物不含抗菌剂三氯生（即2,4,4'-三氯-2'-羟基 - 二苯基醚），在短时间内具有高杀菌活性，提供稳定的大量泡沫并显示出增强的组织 （例如皮肤）兼容性，由体外全毒理学评估方法定义。

公开(公告)号：US20150087717A1

公开(公告)日：2015-03-26

申请号：US14561447

申请日：2014-12-05

Applicant: Ecolab USA Inc.

Inventor： Daniel E. Pedersen ,  Angela R. Eder ,  Charles Allen Hodge

IPC: A01N25/30 ,  A01N47/44 ,  A01N33/12

CPC classification number: A61K8/43 ,  A01N25/16 ,  A01N25/30 ,  A01N33/12 ,  A01N47/44 ,  A61K8/40 ,  A61K8/416 ,  A61K8/60 ,  A61K8/604 ,  A61K2800/30 ,  A61Q17/005 ,  A61Q19/10 ,  C11D1/62 ,  C11D1/662 ,  C11D1/75 ,  C11D1/835 ,  C11D1/88 ,  C11D1/94 ,  C11D3/22 ,  C11D3/30 ,  A01N2300/00

Abstract: The antimicrobial composition of the present invention comprises a cationic active ingredient, a quaternized sugar-derived surfactant, and an optional foam boosting surfactant. These formulations have a high cidal activity in a short amount of time and provide stable copious foam. The formulations of the present invention also exhibit enhanced tissue (e.g. skin) compatibility as defined by an in vitro whole toxicology assessment method.

Abstract translation: 本发明的抗微生物组合物包含阳离子活性成分，季铵化的糖衍生的表面活性剂和任选的泡沫促进表面活性剂。 这些制剂在短时间内具有高的杀螨活性并提供稳定的大量泡沫。 本发明的制剂还表现出由体外全毒理学评估方法所定义的增强的组织（例如皮肤）相容性。